Olmevas AM 5 mg+20 mg (Tablet)
Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00)
Strip Price: ৳ 120.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Amlodipine besilate olmesartan medoxomil |
| Company | Popular pharmaceuticals ltd |
| Also available as |
Indications
- Treatment of hypertension
- Lowering blood pressure
- Initial therapy for multiple antihypertensive agents
Pharmacology
- Dihydropyridine calcium channel blocker
- Inhibition of transmembrane influx of calcium ions
- Peripheral arterial vasodilator
- Blockage of vasoconstrictor and aldosterone-secreting effects of angiotensin II
- Selective blocking of AT1 receptor
- Reversible, competitive inhibitor of the AT1 receptor
Dosage & Administration
- 5/20 mg once daily for 1 to 2 weeks as initial therapy
- Titration up to a maximum of 10/40 mg once daily
- Recommended starting dose of Amlodipine is 2.5 mg in patients 75 years
- Increased amounts of Amlodipine, Olmesartan Medoxomil, or both as needed
Interaction
- Attenuation of antihypertensive effect by NSAIDs including selective COX-2 inhibitors
- Close monitoring of blood pressure, renal function, and electrolytes in combination therapy
Contraindications
- Co-administration with Aliskiren in patients with diabetes
Side Effects
- Peripheral edema
- Headache
- Flushing
- Dizziness
- Sprue-like enteropathy
Pregnancy & Lactation
- Pregnancy Category D
- Avoid use in 2nd and 3rd trimester
- Potential excretion in human milk
Precautions & Warnings
- Risk for hypotension in volume- or salt-depleted patients
- Risk for vasodilation in patients with severe aortic stenosis
- Increased frequency, duration, or severity of angina or acute MI in patients with severe obstructive coronary artery disease
Use in Special Populations
- Safety and effectiveness not established in pediatric patients
- No overall differences in safety or effectiveness observed between subjects 65 years of age or older and younger subjects
- No studies in patients with renal impairment
- Initial therapy not recommended in hepatically impaired patients
Overdose Effects
- No information on overdose in humans
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of the reach of children